Ryvu Company
Ryvu is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.
Employee Number:
101-250
Funding Status:
IPO
Headquarters:
Krakow, Malopolskie, Poland
Technology:
Small Molecules
Estimated Revenue:
$50M to $100M
Founded Date:
2007
Industry:
PharmTech